Skip to content

Jenny L Wiley

3 papers in the library · 233 citations · publishing 2003-2014

Papers

Sort Most recent Most cited

Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

Journal of Neuroscience November 12, 2014 Michael H. Baumann, Ernesto Solis, Lucas R. Watterson et al. 157 citations

The abuse of synthetic psychoactive substances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., "bath salts") and synthetic cannabinoids (i.e.,...

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.

Psychopharmacology June 1, 2010 D Matthew Walentiny, Robert E Vann, Jonathan A Warner et al. 49 citations

Salvinorin A, the primary psychoactive derivative of the hallucinogenic herb Salvia divinorum, is a potent and highly selective kappa-opioid receptor (KOR) agonist. Several recent studies, however, have suggested endocannabinoid system mediation of some of its effects. This study represents a systematic examination of this hypothesis. Salvinorin A was isolated from S. divinorum and was...

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

Psychopharmacology February 1, 2003 Jenny L Wiley, Sarah A Harvey, Robert L Balster et al. 27 citations

Phencyclidine (PCP) binds with high affinity to a site located within the ionophore of N-methyl- D-aspartate (NMDA) receptors. Previous studies have demonstrated that PCP and other high-affinity NMDA channel blockers reliably disrupt prepulse inhibition (PPI) of acoustic startle, an animal model of sensorimotor gating used to study attentional deficits associated with schizophrenia. Recently, a...